Cardinal Health's dismal forecast drags rivals, drugmakers down

Cardinal Health Inc forecast fiscal year 2018 profit well below analyst estimates, highlighting the drag on drug distributors and generic drugmakers due to stubbornly low generic drug prices.The company's shares slumped as much as 9.8 percent, whilerivals McKesson Corp were down nearly 3 percent and AmerisourceBergen Corp 4 percent.Generic drugmakers Teva Pharmaceutical Industries Ltd and Mylan NV were also lower on Wednesday.